[Management of Crohn's disease after intestinal resection].
Medizinische Klinik und Poliklinik B, Universitätsklinikum Münster, Deutschland.
D
D
Bettenworth
Agaplesion Markus Krankenhaus, Frankfurt, Deutschland.
A
A
Dignass
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy* / Q000601:surgery* / Q000628:therapy*; D013505:Digestive System Surgical Procedures; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents